An FDA clearance and dry eye disease trials led cornea coverage from December.
Read the best-performing pieces of cornea coverage from December below.FDA clears TearCare system for treatment of meibomian gland dysfunction
The TearCare system has received 510(k) clearance from the FDA for the treatment of meibomian gland dysfunction, according to a press release from Sight Sciences. Read more.
VIDEO: Cross-linking ‘one of the most disruptive’ procedures in ophthalmology
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Eric D. Donnenfeld, MD, discusses the